Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma

NCT02843386 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT02843386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02843386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase III Study Comparing an Adjuvant Chemotherapy With Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma
Lead sponsor
Institut Curie
Phase
Phase 3
Overall status
Completed
Start date
June 23, 2009
Completion date
June 12, 2020
Enrollment
302 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

uveal melanoma